Novel evidence of the involvement of calreticulin in major psychiatric disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 37, Issue 2, 2012, Pages 276-281

  Ohadi, M ^a   Mirabzadeh, A ^a   Esmaeilzadeh Gharehdaghi, E ^a   Rezazadeh, M ^a   Hosseinkhanni, S ^b   Oladnabi, M ^a   Firouzabadi, S Ghasemi ^a   Darvish, H ^a  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Calreticulin; Intron; Mutation; Promoter; Psychiatric disorder: valproic acid

Indexed keywords

CALRETICULIN; VALPROIC ACID;

ANIMAL CELL; ARTICLE; BINDING SITE; CALRETICULIN GENE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; GENE INSERTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MENTAL DISEASE; MOUSE; MUTATIONAL ANALYSIS; MUTATOR GENE; NONHUMAN; PROMOTER REGION; SEQUENCE ANALYSIS;

ANTIMANIC AGENTS; CALRETICULIN; CASE-CONTROL STUDIES; CELL LINE; CELLS, CULTURED; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MENTAL DISORDERS; PROMOTER REGIONS, GENETIC; VALPROIC ACID;

EID: 84859590826     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.02.007     Document Type: Article

References (35)

1. Aghajani A., Rahimi A., Fadai F., Ebrahimi A., Najmabadi H., Ohadi M. A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2006, 141B:294-295.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders-Text Revised 2000, APA, Washington. DC.
3. Arion D., Unger T., Lewis D.A., Levitt P., Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biological Psychiatry 2007, 62:711-721.
4. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008, 40:695-701.
5. Bown C.D., Wang J.F., Chen B., Young L.T. Regulation of ER stress proteins by valproate: therapeutic implications. Bipolar Disorders 2002, 4:145-151. Review.
6. Brawand D., Soumillon M., Necsulea A., Julien P., Csárdi G., Harrigan P., et al. The evolution of gene expression levels in mammalian organs. Nature 2011, 478(7369):343-348.
7. Caligiuri M.P., Hellige J.B., Cherry B.J., Kwok W., Lulow L.L., Lohr J.B. Lateralized cognitive dysfunction and psychotic symptoms in schizophrenia. Schizophrenia Research 2005, 80:151-161.
8. Corson T.W., Woo K.K., et al. Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs. European Neuropsychopharmacology 2004, 14:143-150.
9. De Lima A.D., Gieseler A., Voigt T. Relationship between GABAergic interneurons migration and early neocortical network activity. Developmental Neurobiology 2009, 69:105-123.
10. Doherty J., O'Donovan M., Owen M. Recent genomic advances in schizophrenia. Clinical Genetics 2011, 10.1111/j.1399-0004.2011.01773.x.
11. Esmaeilzadeh-Gharehdaghi E., Banan M., Farashi S., Mirabzadeh A., Farokhashtiani T., Hosseinkhani S., et al. Support for down tuning of the calreticulin gene in the process of evolution to humans. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011, 35:1770-1773.
12. Farokhashtiani T., Mirabzadeh A., Olad Nabi M., Ghaem Magham Z., Khorram Khorshid H.R., Najmabadi H., et al. Reversion of the human calreticulin gene promoter to the ancestral type as a result of a novel psychosis-associated mutation. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011, 35:541-544.
13. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 2005, 10:40-68.
14. Hayashi T., Justinova Z., Hayashi E., Cormaci G., Mori T., Tsai S.Y., et al. Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats. Journal of Pharmacology and Experimental Therapeutics 2010, 332:1054-1063.
15. Higashino A., Kageyama T. Development-dependent expression of calreticulin in the brain and other tissues of the Japanese monkey, Macaca fuscata. Journal of Medical Primatology 2008, 37:303-310.
16. Horiuchi Y., Iida S., Koga M., Ishiguro H., Iijima Y., Inada T., et al. Association of SNPs linked to increased expression of SLC1A1 with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2012 Jan, 159B(1):30-37.
17. Iwamoto K., Kato T. Gene expression profiling in schizophrenia and related mental disorders. The Neuroscientist 2006, 12:349-361.
18. Jaskolski F., Normand E., Mulle C., Coussen F. Differential trafficking of GluR7 kianate receptor subunit splice variants. J Biol Chem 2005, 280:22968-22976.
19. Jegga A.G., Sherwood S.P., Carman J.W., Pinski A.T., Phillips J.L., Pestian J.P., et al. Detection and visualization of compositionally similar cis-regulatory element clusters in orthologous and coordinately controlled genes. Genome Research 2002, 12:1408-1417.
20. Kakiuchi C., Iwamoto K., Ishiwata M., Bundo M., Kasahara T., Kusumi I., et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nature Genetics 2003, 35:171-175.
21. Kim A.J., Shi Y., Austin R.C., Werstuck G.H. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. Journal of Cell Science 2005, 118(Pt 1):89-99.
22. Matigian N., Windus L., Smith H., Filipich C., Pantelis C., McGrath J., et al. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signaling pathway. Molecular Psychiatry 2007, 12:815-825.
23. Michalak M., Corbett E.F., Mesaeli N., Nakamura K., Opas M. Calreticulin: one protein, one gene, many functions. Biochem J 1999, 344:281-292.
24. Mohrluder J., et al. Identification of calreticulin as a ligand of GABARAP by phage display screening of a peptide library. FEBS Journal 2007, 274:5543-5555.
25. Nakamura M., Sato K., Fukaya M., Araishi K., Aiba A., Kano M., et al. Signaling complex formation of phospholipase Cβ4 with metabotropic glutamate receptor type 1α and 1, 4, 5-trisphosphate receptor at the perisynapse and endoplasmic reticulum in the mouse brain. Eur J Neurol 2004, 20:2929-2944.
26. Nunes A., Ohadi M., Rahimi A., Aghajani A., Najmabadi H., Curraisa A., et al. A mutation in the calreticulin gene promoter in a family case of schizoaffective disorder leads to its aberrant transcriptional activation. Brain Research 2008, 1239:36-41.
27. Olad Nabi M., Mirabzadeh A., Feizzadeh G., Khorshid H.R., Karimlou M., Yeganeh M.Z., et al. Novel mutations in the calreticulin gene core promoter and coding sequence in schizoaffective disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2010, 153B(2):706-709.
28. Olkku A., Mahonen A. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells. Bone 2009, 44:555-565.
29. Sager J.J., Torres G.E. Proteins interacting with monoamine transporters: current state and future challenges. Biochemistry 2011, 50:7295-7310.
30. Sequeira A., Klempan T., Canetti L., ffrench-Mullen J., Benkelfat C., Rouleau G.A., et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Molecular Psychiatry 2007, 12:640-655.
31. Shao L., Sun X., Xu L., Young L.T., Wang J.F. Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sciences 2006, 78:1317-1323.
32. Shimo H., Nakamura M., Tomiyasu A., Ichiba M., Ueno S., Sano A. Comprehensive analysis of the genes responsible for neuroacanthocytosis in mood disorder and schizophrenia. Neurosciences Research 2011, 69:196-202.
33. Singaraja R.R., Bocher V., James E.R., Clee S.M., Zhang L.H., Leavitt B.R., et al. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. Journal of Biological Chemistry 2001, 276:33969-33979.
34. Tate C.G., Whiteley E., Betenbaugh M.J. Molecular chaperones stimulate the functional expression of the cocaine-sensitive serotonin transporter. Journal of Biological Chemistry 1999, 274(25):17551-17558.
35. Yamada K., Gerber D.J., Iwayama Y., Ohnishi T., Ohba H., Toyota T., et al. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:2815-2820.